Literature DB >> 21126888

A preliminary evaluation of multi-probe resonance-frequency electrical impedance based measurements of the breast.

Bin Zheng1, Dror Lederman, Jules H Sumkin, Margarita L Zuley, Michelle Z Gruss, Linda S Lovy, David Gur.   

Abstract

RATIONALE AND
OBJECTIVES: The aim of this study was to preliminarily assess the performance of a new, resonance-frequency electrical impedance spectroscopy (REIS) system in identifying young women who were recommended to undergo breast biopsy following imaging.
MATERIALS AND METHODS: A seven-probe REIS system was designed and assembled and is currently being prospectively tested. During examination, contact is made with the nipple and six concentric points on the breast skin. Signal sweeps are performed, and outputs ranging from 200 to 800 kHz at 5-kHz intervals are recorded. An initial set of 140 patients, including 56 who eventually had biopsies, 63 who had negative results on screening mammography, and 21 recalled for additional imaging but later determined to have negative results, was used. An initial set of 35 features, 33 representing impedance signal differences between breasts and two representing participant age and average breast density, was assembled and reduced by a genetic algorithm to 14. The performance of an artificial neural network-based classifier was assessed using a case-based leave-one-out method.
RESULTS: The substantially greater asymmetry between signals of mirror-matched regions ascertained from biopsy ("positive") compared to nonbiopsy ("negative") cases resulted in an artificial neural network classifier performance (area under the curve) of 0.830 ± 0.023. At 90% specificity, this classifier, optimized for "recommendation for biopsy" rather than "cancer," detected 30 REIS-positive cases (54%), including six of nine (67%) actual cancer cases and six of nine women (67%) recommended for surgical excision of high-risk lesions.
CONCLUSIONS: Asymmetry in impedance measurements between bilateral breasts may provide valuable discriminatory information regarding the presence of highly suspicious imaging-based findings. Copyright Â
© 2011 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21126888      PMCID: PMC3021623          DOI: 10.1016/j.acra.2010.09.017

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  26 in total

1.  Performance gain in computer-assisted detection schemes by averaging scores generated from artificial neural networks with adaptive filtering.

Authors:  B Zheng; Y H Chang; W F Good; D Gur
Journal:  Med Phys       Date:  2001-11       Impact factor: 4.071

2.  Novel EIS postprocessing algorithm for breast cancer diagnosis.

Authors:  Yaël A Glickman; Orna Filo; Udi Nachaliel; Sarah Lenington; Sigal Amin-Spector; Ron Ginor
Journal:  IEEE Trans Med Imaging       Date:  2002-06       Impact factor: 10.048

3.  Electromagnetic breast imaging: average tissue property values in women with negative clinical findings.

Authors:  Steven P Poplack; Keith D Paulsen; Alexander Hartov; Paul M Meaney; Brian W Pogue; Tor D Tosteson; Margaret R Grove; Sandra K Soho; Wendy A Wells
Journal:  Radiology       Date:  2004-05       Impact factor: 11.105

4.  Dielectric properties of breast carcinoma and the surrounding tissues.

Authors:  A J Surowiec; S S Stuchly; J B Barr; A Swarup
Journal:  IEEE Trans Biomed Eng       Date:  1988-04       Impact factor: 4.538

5.  Electrical impedance scanning for classifying suspicious breast lesions: first results.

Authors:  A Malich; T Fritsch; R Anderson; T Boehm; M G Freesmeyer; M Fleck; W A Kaiser
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

Review 6.  Breast cancer screening among women younger than age 50: a current assessment of the issues.

Authors:  R A Smith
Journal:  CA Cancer J Clin       Date:  2000 Sep-Oct       Impact factor: 508.702

7.  Breast cancer screening by impedance measurements.

Authors:  G Piperno; E H Frei; M Moshitzky
Journal:  Front Med Biol Eng       Date:  1990

8.  Electrical impedance spectroscopy of the breast: clinical imaging results in 26 subjects.

Authors:  Todd E Kerner; Keith D Paulsen; Alex Hartov; Sandra K Soho; Steven P Poplack
Journal:  IEEE Trans Med Imaging       Date:  2002-06       Impact factor: 10.048

9.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

Authors:  Mieke Kriege; Cecile T M Brekelmans; Carla Boetes; Peter E Besnard; Harmine M Zonderland; Inge Marie Obdeijn; Radu A Manoliu; Theo Kok; Hans Peterse; Madeleine M A Tilanus-Linthorst; Sara H Muller; Sybren Meijer; Jan C Oosterwijk; Louk V A M Beex; Rob A E M Tollenaar; Harry J de Koning; Emiel J T Rutgers; Jan G M Klijn
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

10.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Authors:  Ellen Warner; Donald B Plewes; Kimberley A Hill; Petrina A Causer; Judit T Zubovits; Roberta A Jong; Margaret R Cutrara; Gerrit DeBoer; Martin J Yaffe; Sandra J Messner; Wendy S Meschino; Cameron A Piron; Steven A Narod
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

View more
  3 in total

1.  Classification of thyroid nodules using a resonance-frequency-based electrical impedance spectroscopy: a preliminary assessment.

Authors:  Bin Zheng; Mitchell E Tublin; Amy H Klym; David Gur
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

2.  Diagnostic accuracy and prognostic value of three-dimensional electrical impedance tomography imaging in patients with breast cancer.

Authors:  Feng Xu; Mengxin Li; Jie Li; Hongchuan Jiang
Journal:  Gland Surg       Date:  2021-09

3.  Noninvasive pulmonary nodule characterization using transcutaneous bioconductance: Preliminary results of an observational study.

Authors:  Joanna Gariani; Steve P Martin; Anne-Lise Hachulla; Wolfram Karenovics; Dan Adler; Paola M Soccal; Chirstoph D Becker; Xavier Montet
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.